In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

The first patient in the United States has been treated with Rapiblyk® (landiolol) at The Valley Hospital, Paramus, NJ.

The above video shows the top local headlines for the morning of April 28, 2026. LUBBOCK, Texas — Covenant Health announced ...

AOP Health US, LLC today announced that the first patient in the United States has been treated with Rapiblyk (landiolol) at The Valley Hospital, Paramus, NJ. This marks a key milestone in the company ...

Pulse Biosciences (Nasdaq:PLSE) today announced new positive clinical findings for its nPulse cardiac catheter system.

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...

Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

Catheter ablation is an important treatment modality for patients with atrial fibrillation (AF). Although the superiority of catheter ablation over antiarrhythmic drug therapy has been demonstrated in ...

More rigorous randomized data are needed, which could be challenging in light of the drugs’ indication based on BMI.

Bisphosphonates are an effective treatment for osteoporosis, but several trials reported an association between use of these drugs and an increased risk of atrial fibrillation and flutter; other ...

Early commercial use of transcatheter tricuspid valve replacement shows some improvements ...